Cover Image

Intratumoral administration of daromun in non‐melanoma skin cancer: Preliminary results from a phase 2 non‐randomized controlled trial

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Lukas Flatz, Nikolaus B. Wagner, Natalja Denisjuk, Peter Do, Lisa Nadal, Emanuele Puca, Giuliano Elia, Alfredo Covelli, Dario Neri, Antonio Cozzio
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of the European Academy of Dermatology and Venereology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Precision medicine in cutaneous melanoma—A comprehensive review
by: Markus Reitmajer, et al.
Published: (2025)

Metformin is not associated with decreased risk of non‐melanoma skin cancer: A distributed network analysis of 14 real‐world databases in Korea
by: Da‐Hyun Kang, et al.
Published: (2024)

Genetic susceptibility in early‐onset melanoma: An observational Greek cohort study
by: Eftychia Chatziioannou, et al.
Published: (2025)

Towards evidence‐based policy in melanoma screening and skin self‐examination education
by: Sinem Ornek Ozdemir, et al.
Published: (2025)

Assessing UWB‐RSOM for non‐invasive melanoma depth: Diagnostic potential and critical limitations
by: Shiuan‐Chih Chen, et al.
Published: (2025)

Suicidality in patients with skin diseases: What dermatologists need to know?
by: Emanuele Scala, et al.
Published: (2025)

Effect of patient‐contextual skin images in human‐ and artificial intelligence‐based diagnosis of melanoma: Results from the 2020 SIIM‐ISIC melanoma classification challenge
by: Nicholas R. Kurtansky, et al.
Published: (2024)

Response to Letter to the Editor—Assessing UWB ‐ RSOM for non‐invasive melanoma depth: Diagnostic potential and critical limitations
by: Juan Aguirre, et al.
Published: (2025)

JAK inhibitor treatment for non‐infectious granulomatous skin diseases—A retrospective case study
by: Robin Springer, et al.
Published: (2026)

Reporting of skin colour in randomized controlled trials on vitiligo: A systematic review
by: Meghna Varambally, et al.
Published: (2025)

Adjuvant treatment for acral melanoma
by: Takaya Komori, et al.
Published: (2026)

Cutaneous melanoma in adolescents and young adults
by: Alessandra Buja, et al.
Published: (2024)

Melanocytic clefting is associated with melanoma on LC ‐ OCT
by: J. Pérez‐Anker, et al.
Published: (2025)

Advancing AI models for enhanced melanoma diagnosis
by: François Kuonen, et al.
Published: (2025)

Moles and melanomas on tattoos: Where we are in 2025
by: Nicolas Kluger
Published: (2025)

The quest for missing risk factors to predict melanoma
by: M. Wakkee, et al.
Published: (2025)

Bullying and skin diseases
by: C. Szabó
Published: (2024)

Associations of skin cancer, dermatitis and risk factors for skin conditions with epigenetic aging
by: Raj P. Fadadu, et al.
Published: (2026)

Top weapons in skin aging and actives to target the consequences of skin cell senescence
by: Z. Draelos, et al.
Published: (2024)

Exploring blood cell biomarkers in melanoma patients receiving adjuvant anti‐ PD ‐1 immunotherapy
by: Renan de Jesus Teixeira, et al.
Published: (2025)

MAPK activity as a surrogate of acral melanoma immunogenicity?
by: Rastine Merat
Published: (2025)

Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma
by: Inga Hansen, et al.
Published: (2024)

Control of rapidly progressing melanoma metastases during pregnancy
by: Isabel Wolff, et al.
Published: (2025)

Family history in melanoma risk: Revisiting criteria for surveillance
by: Annemiek Leeman, et al.
Published: (2025)

Diving beyond surface perceptions of melanoma diagnosis and screening
by: Efthymia Soura, et al.
Published: (2024)

Pregnancy‐associated melanoma: A distinct entity requiring vigilance
by: Maria Kostaki, et al.
Published: (2026)

Age matters: Rethinking SLNB's reliability in melanoma mortality prediction
by: Christoffer Gebhardt
Published: (2024)

Pregnancy‐associated melanoma epidemiology: A multicentre European study
by: Maria Kostaki, et al.
Published: (2025)

Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas
by: Damien Sanogo, et al.
Published: (2025)

Acral melanoma: Molecular subtyping as a gateway to precision medicine
by: Emi Dika, et al.
Published: (2025)

Indoor tanning: Smoking for the skin
by: Clio Dessinioti, et al.
Published: (2026)

Differing features of pemphigus in skin of colour versus white skin: A broad‐scale cohort study
by: M. Kasperkiewicz, et al.
Published: (2024)

Glutathione amino acid precursors protect skin from UVB‐induced damage and improve skin tone
by: Xiao Cui, et al.
Published: (2024)

Melanocytic clefting in melanoma: Reassessing its role in diagnostic decision‐making
by: Shiuan‐Chih Chen, et al.
Published: (2025)

Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma
by: Dirk Tomsitz, et al.
Published: (2025)

Melanosis and isolated follicular vitiligo during checkpoint inhibitors for metastatic melanoma
by: Valentine Salvestrini, et al.
Published: (2024)

Epithelial microabscessing in neutrophilic skin diseases
by: Enno Christophers
Published: (2024)

The mind–skin connection: A narrative review exploring the link between inflammatory skin diseases and psychological stress
by: G. Biazus Soares, et al.
Published: (2024)

Revisiting the evidence: UV exposure, melanoma and the need for smarter public health strategies
by: Efthymia Soura, et al.
Published: (2025)

Enhancing HFUS accuracy in melanoma assessment: The role of artificial intelligence and statistical precision
by: I. Chen, et al.
Published: (2024)